Esbriet® (pirfenidone) for Idiopathic Pulmonary Fibrosis ...

Learn about Esbriet® (pirfenidone), a medicine for treating idiopathic pulmonary fibrosis, a progressive and irreversible fibrotic interstitial lung disease. See ...

Esbriet Uses, Dosage & Side Effects - Drugs.com

Esbriet (pirfenidone) is used to treat Idiopathic Pulmonary Fibrosis. Includes Esbriet side effects, interactions and indications.

Esbriet® (pirfenidone) Dosage - How to Take Esbriet ...

Learn about Esbriet® (pirfenidone) dosage and how to take Esbriet. See full safety for more information.

Pirfenidone - Wikipedia

Pirfenidone; Clinical data; Trade names: Esbriet, Pirespa, Etuary: AHFS/Drugs.com: International Drug Names: License data

ESBRIET - Pirfénidone - Posologie, Effets secondaires ...

ESBRIET : Esbriet est indiqué chez l'adulte pour le traitement de la fibrose pulmonaire idiopathique légère à modérée (FPI).

Common Side Effects of Esbriet (Pirfenidone Capsules) Drug ...

Find a comprehensive guide to possible side effects including common and rare side effects when taking Esbriet (Pirfenidone Capsules) for healthcare professionals and ...

Esbriet (Pirfenidone Capsules): Side Effects, Interactions ...

Learn about Esbriet (Pirfenidone Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

Esbriet - FASS Allmänhet

Esbriet innehåller det aktiva ämnet pirfenidon och det används för att behandla lindrig till måttlig idiopatisk lungfibros (IPF) hos vuxna.

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do ...

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ESBRIET safely and effectively. See full prescribing ...

Esbriet 267 mg Hard Capsules - Summary of Product ...

Esbriet 267 mg Hard Capsules - Summary of Product Characteristics (SmPC) by Roche Products Limited